CytoReason
@cytoreason.bsky.social
CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models.
Our science advisory board member, Dr. Tom Bumol believes that to develop a robust disease model, you need to map every outcome - successes, failures, and surprises - along the drug development journey.
See his recent interview with our Chief Scientist, Shai Shen-Orr:
www.cytoreason.com/podcast/
See his recent interview with our Chief Scientist, Shai Shen-Orr:
www.cytoreason.com/podcast/
February 6, 2025 at 12:52 PM
Our science advisory board member, Dr. Tom Bumol believes that to develop a robust disease model, you need to map every outcome - successes, failures, and surprises - along the drug development journey.
See his recent interview with our Chief Scientist, Shai Shen-Orr:
www.cytoreason.com/podcast/
See his recent interview with our Chief Scientist, Shai Shen-Orr:
www.cytoreason.com/podcast/